冷凍切除的全球市場:預測(2022年~2028年)
市場調查報告書
商品編碼
1123244

冷凍切除的全球市場:預測(2022年~2028年)

Global Cryoablation Market Research and Forecast 2022-2028

出版日期: | 出版商: Orion Market Research | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

全球冷凍切除的市場規模在預測期間(2022年~2028年)內預計將以11.2%的年複合成長率增長。癌症等慢性病患病率的增加、生活方式的改變以及研發投資的增加是推動冷凍消融市場增長的主要因素。

本報告提供全球冷凍切除市場相關調查分析,提供市場概要,競爭情形,市場分析,企業簡介等系統性資訊。

目錄

類別:醫療設備 1. 報告概要

  • 調查方法與工具
  • 市場明細
    • 各市場區隔
    • 各地區

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • 企業佔有率分析
  • 主要策略分析
  • 主要企業分析

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 機會

第5章 市場區隔

  • 全球冷凍切除市場:各用途
    • 腫瘤
    • 心臟病
    • 其他
  • 全球冷凍切除市場:各終端用戶
    • 醫院
    • 專門診所
    • 門診病人手術中心

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 全球其他地區

第7章 企業簡介

  • Adagio Medical, Inc.
  • AngioDynamics, Inc.
  • AtriCure, Inc.
  • ATS Medical, Inc.
  • BioSig Technologies, Inc.
  • Boston Scientific Corp.
  • CPSI Biotech
  • HealthTronics, Inc.
  • IceCure Medical
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC.
  • Olympus Corp.
  • Sanarus Technologies, Inc.
  • Stryker Corp.
Product Code: OMR2018396

Global Cryoablation Market Size, Share & Trends Analysis Report By Application (Oncology, Cardiology, Others), and By End-User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), Forecast Period 2021-2027

The global cryoablation market is expected to grow at an impressive CAGR of 11.2% during the forecast period. The major factors that are augmenting the growth of the cryoablation market include an increase in the prevalence of chronic diseases such as cancer and changing lifestyles. In addition, the acceptance of minimally invasive technology and increasing investments in R&D are other major factors augmenting the market growth. The emerging application of this therapy will turn out to be a huge opportunity for the cryoablation market.

Cryosurgery is used to treat several types of cancer and some precancerous conditions. In addition to cryosurgery, prostate, and liver tumors, cryoablation can be an effective treatment for retinoblastoma, early-stage skin cancers, actinic keratosis, and cervical cancer. Treatment is based on a 20-40 second application (multiple if needed) of a refillable metallic probe that is electrically heated to approximately 100 °C, most important to epithelial and stromal destruction. Cryotherapy ablation is providing by a diversity of healthcare professionals, including primary healthcare workers, and typically performed without anesthesia. Cryosurgery is also used to treat some types of low-grade cancerous and noncancerous tumors of the bone. Cryoablation moderates the risk of joint damage while compared with more extensive surgery and helps reduce the need for exclusion. The treatment is also used to treat AIDS-related Kaposi sarcoma when the skin injuries are small and confined.

However, certain factors are affecting the growth of the cryoablation market such as refrigerant gas (N2O or CO2) that are used in cryotherapy the gas containers are heavy and bulky to transport and in the emerging and low-income countries (LMICs) may have supply issues. Refilling freezing gas can be costly. Moreover, in July 2020, Healio announced the US FDA expands clearance of cryoablation technology for the treatment of head, kidney, liver, and neck tumors. In January 2020, IceCure Medical Ltd. announced the US FDA approval for its cryoablation technology, the approval enables the Company to market its solution for the treatment of cancerous and non-threatening tumors of the liver, Kidney, Ear, Nose, and Throat (ENT).

Segmental Outlook

The global cryoablation market is segmented based on application and end-user. Based on application, the market is segmented into oncology, cardiology, and others. The oncology segment is projected for the largest share of the cryoablation market in 2020. The market is growing due to the rising prevalence of cancer, product enhancements, and increasing government funding for cancer research. and the increasing adoption of Yttrium-90 cardioembolic agents in developing countries. Further, based on end-user, the market is sub-segmented into hospitals, clinics, and ambulatory surgical centers.

Global Cryoablation Market Share by Application, 2020 (%)

Global Cryoablation Market Share by Application

Regional Outlook

The global cryoablation market is analyzed based on the geographical regions that are contributing significantly to the growth of the market. The market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific) and Rest of the World (RoW). North America is estimated to be the leading region in the global cryoablation market. The prevalence of cancer is one of the major factors driving the growth of the market in the region. The Asia-Pacific is estimated to be the fastest-growing region during the forecast period 2021-2027.

Global Cryoablation Market Growth, by Region 2021-2027

Global Cryoablation Market Share by region

Asia-Pacific to register considerable growth in the global cryoablation market

In Asia-Pacific, the cryoablation market is driven by various factors including an increased prevalence of cancer and cardiovascular disease and government funding on cancer research. China is expected to be one of the leading countries the due to rising prevalence of cardiac diseases such as heart stroke and the development of cardiovascular devices in the country.

Market Players Outlook

Key players of the global cryoablation market include Medtronic Inc., Boston Scientific Corp., Johnson & Johnson Services, Inc., AtriCure, Inc., and CooperSurgical. To survive in the market these players adopt different marketing strategies such as a merger, acquisitions, product launches, geographical expansion, charities so on. For instance, in February 2020, Boston Scientific Corp. received CE Mark for the POLARx Cryoablation System, which is designated for the treatment of patients with paroxysmal atrial fibrillation (AF), an intermittent form of AF which causes an irregular and often abnormally fast heart rate.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global cryoablation market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Cryoablation Market by Application
    • 5.1.1. Oncology
    • 5.1.2. Cardiology
    • 5.1.3. Other
  • 5.2. Global Cryoablation Market by End-User
    • 5.2.1. Hospitals
    • 5.2.2. Specialty Clinics
    • 5.2.3. Ambulatory Surgical Centers

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Adagio Medical, Inc.
  • 7.2. AngioDynamics, Inc.
  • 7.3. AtriCure, Inc.
  • 7.4. ATS Medical, Inc.
  • 7.5. BioSig Technologies, Inc.
  • 7.6. Boston Scientific Corp.
  • 7.7. CPSI Biotech
  • 7.8. HealthTronics, Inc.
  • 7.9. IceCure Medical
  • 7.10. Johnson & Johnson Services, Inc.
  • 7.11. Medtronic PLC.
  • 7.12. Olympus Corp.
  • 7.13. Sanarus Technologies, Inc.
  • 7.14. Stryker Corp.

LIST OF TABLES

  • 1. GLOBAL CRYOABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 2. GLOBAL ONCOLOGY MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 3. GLOBAL CARDIOLOGY MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 4. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 5. GLOBAL CRYOABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 6. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 7. GLOBAL SPECIALTY CLINICS MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 8. GLOBAL AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)

9. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($MILLION)

10. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($MILLION)

11. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($MILLION)

12. EUROPEAN MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($MILLION)

13. EUROPEAN MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($MILLION)

14. EUROPEAN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($MILLION)

15. ASIA-PACIFIC MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($MILLION)

16. ASIA-PACIFIC MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($MILLION)

17. ASIA-PACIFIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($MILLION)

18. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($MILLION)

19. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($MILLION)

LIST OF FIGURES

  • 1. GLOBAL CRYOABLATION MARKET BY APPLICATION, 2020 VS 2027(%)
  • 2. GLOBAL CRYOABLATION MARKET BY END-USER, 2020 VS 2027(%)
  • 3. GLOBAL CRYOABLATION MARKET BY GEOGRAPHY, 2020 VS 2027(%)
  • 4. GLOBAL ONCOLOGY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027(%)
  • 5. GLOBAL CARDIOLOGY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027(%)
  • 6. GLOBAL OTHER MARKET SHARE BY GEOGRAPHY, 2020 VS 2027(%)
  • 7. GLOBAL HOSPITALS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027(%)
  • 8. GLOBAL SPECIALTY CLINICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027(%)
  • 9. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027(%)
  • 10. US CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. CANADA CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. UK CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. GERMANY CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. SPAIN CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. FRANCE CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. ITALY CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. REST OF EUROPE CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. INDIA CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. CHINA CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. JAPAN CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. REST OF THE WORLD CRYOABLATION MARKET SIZE, 2020-2027 ($ MILLION)